Sign in

CIK 0001367644 · Accelerated filer

Emergent BioSolutions Inc.

Sign in to watch
Ticker
EBS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
141902018
Phone
240-631-3200
Business address
300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$145,792
in 2 filings, $146K under 10b5-1 plans

Net −$145,792. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-02-24 Strei Katherine EVP, Chief HR Officer Shares withheld for taxes −590 $42.47 $25K 30,208
2022-02-24 SARAN ATUL EVP, Corp Dev, GC & Secretary Shares withheld for taxes −857 $42.47 $36K 43,213
2022-02-24 LINDAHL RICHARD S EVP, Chief Financial Officer Shares withheld for taxes −983 $42.47 $42K 37,958
2022-02-24 Kramer Robert President and CEO Shares withheld for taxes −2,034 $42.47 $86K 159,269
2022-02-24 Havey Adam EVP, Business Operations Shares withheld for taxes −828 $42.47 $35K 36,794
2022-02-23 Strei Katherine EVP, Chief HR Officer Shares withheld for taxes −344 $42.23 $15K 30,798
2022-02-23 SARAN ATUL EVP, Corp Dev, GC & Secretary Shares withheld for taxes −442 $42.23 $19K 44,070
2022-02-23 LINDAHL RICHARD S EVP, Chief Financial Officer Shares withheld for taxes −516 $42.23 $22K 38,941
2022-02-23 Kramer Robert President and CEO Shares withheld for taxes −1,419 $42.23 $60K 161,303
2022-02-23 Havey Adam EVP, Business Operations Shares withheld for taxes −424 $42.23 $18K 37,622

Page 17 of 17 · 330 trades